Yağmur Kurak

Dr. Yağmur Kurak

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

24 November 2025 in Neurocirugía (English Edition)
Verified
Journal Article
Closed access
MAmehmet aktoklu
mehmet aktoklu
MBMehmet Orbay Bıyık
Mehmet Orbay Bıyık
ATAli Samet Topsakal
Ali Samet Topsakal
AGAli Riza Guvercin
Ali Riza Guvercin
EÇErtuğrul Çakır
Ertuğrul Çakır
YKYağmur Kurak
Yağmur Kurak

27 December 2025 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
MAmehmet aktoklu
mehmet aktoklu
MBMehmet Orbay Bıyık
Mehmet Orbay Bıyık
ATAli Samet Topsakal
Ali Samet Topsakal
AGAli Riza Guvercin
Ali Riza Guvercin
UYUğur Yazar
Uğur Yazar
EÇErtuğrul Çakır
Ertuğrul Çakır

22 September 2026 in Sağlık Bilimlerinde Değer
Verified
Journal Article
Closed access
MAmehmet aktoklu
mehmet aktoklu
MBMehmet Orbay Bıyık
Mehmet Orbay Bıyık
ATAli Samet Topsakal
Ali Samet Topsakal
YKYağmur Kurak
Yağmur Kurak
AGAli Riza Guvercin
Ali Riza Guvercin
Aim: Transforaminal epidural steroid injection (TFESI) is increasingly used for patients at high risk for invasive surgery. This study evaluated TFESI’s efficacy on functional recovery and examined how advanced age, comorbidities, and neutrophil-to-lymphocyte ratio (NLR) affect clinical outcomes.Material and Methods: This retrospective study included 100 patients with lumbar disc herniation, spinal stenosis, or foraminal narrowing who underwent unilateral TFESI. Oswestry Disability Index (ODI) and Numerical Pain Rating Scale (NPRS) scores were recorded before treatment and at 1, 3, and 6 months post-procedure. Patients were grouped by age (<65 and ≥65 years). Comorbidities, NLR, and pathology level (single/multilevel) were analyzed. Statistical tests used were Friedman, Wilcoxon with Bonferroni correction, Mann-Whitney U, and Kruskal-Wallis.Results: Significant functional improvement and pain reduction occurred early post-TFESI (p<0.001). Younger patients (<65 years) showed faster and greater improvement, while older patients (≥65 years) improved more slowly but significantly. Comorbidities did not significantly affect outcomes. Multilevel pathology and older age were linked to slower recovery. Patients with NLR ≥2.3 had significantly better ODI scores at 6 months (p=0.046).Conclusion: TFESI is a safe and effective treatment even for elderly patients, providing meaningful functional gains despite slower recovery. Multilevel degeneration and comorbidities may hinder recovery speed, whereas NLR could serve as a biological marker predicting treatment response. Beyond pain relief, TFESI aids surgical decision-making and personalized management in complex lumbar diseases.